Banaszkiewicz M, Pietrasik A, Darocha S, Pilka M, Florczyk M, Dobosiewicz A
Arch Med Sci. 2024; 20(5):1442-1451.
PMID: 39649252
PMC: 11623185.
DOI: 10.5114/aoms.2020.98635.
Lee D
J Lipid Atheroscler. 2024; 13(3):262-279.
PMID: 39355403
PMC: 11439747.
DOI: 10.12997/jla.2024.13.3.262.
Newman M, Connery H, Kannan S, Gautam A, Hammamieh R, Chakraborty N
Pharmaceuticals (Basel). 2024; 17(7).
PMID: 39065791
PMC: 11279777.
DOI: 10.3390/ph17070941.
Kayani M, Fatima N, Yarra P, Almansouri N, K D, Balasubramanian A
Cureus. 2024; 16(2):e53445.
PMID: 38435138
PMC: 10909379.
DOI: 10.7759/cureus.53445.
Shao J, Liu C, Wang J
Cancer Innov. 2023; 2(6):439-447.
PMID: 38125765
PMC: 10730003.
DOI: 10.1002/cai2.100.
Risk Factors and Cellular Differences in Heart Failure: The Key Role of Sex Hormones.
Delcuratolo E, Palazzuoli A, Coppi F, Mattioli A, Severino P, Tramonte F
Biomedicines. 2023; 11(11).
PMID: 38002052
PMC: 10669789.
DOI: 10.3390/biomedicines11113052.
Prognostic Value of sST2 in Heart Failure.
Sciatti E, Merlo A, Scangiuzzi C, Limonta R, Gori M, DElia E
J Clin Med. 2023; 12(12).
PMID: 37373664
PMC: 10299183.
DOI: 10.3390/jcm12123970.
Plasma and Urinary Biomarkers Improve Prediction of Mortality through 1 Year in Intensive Care Patients: An Analysis from FROG-ICU.
Davison B, Edwards C, Cotter G, Kimmoun A, Gayat E, Latosinska A
J Clin Med. 2023; 12(9).
PMID: 37176751
PMC: 10179283.
DOI: 10.3390/jcm12093311.
IL-33/ST2 pathway as upper-hand of inflammation in allergic asthma contributes as predictive biomarker in heart failure.
Mehrabi Nasab E, Makoei R, Aghajani H, Athari S
ESC Heart Fail. 2022; 9(6):3785-3790.
PMID: 35975554
PMC: 9773709.
DOI: 10.1002/ehf2.14111.
Biomarkers in Heart Failure with Preserved Ejection Fraction.
Bayes-Genis A, Cediel G, Domingo M, Codina P, Santiago E, Lupon J
Card Fail Rev. 2022; 8:e20.
PMID: 35815256
PMC: 9253965.
DOI: 10.15420/cfr.2021.37.
Mortality Risk Prediction Dynamics After Heart Failure Treatment Optimization: Repeat Risk Assessment Using Online Risk Calculators.
Codina P, Zamora E, Levy W, Revuelta-Lopez E, Borrellas A, Spitaleri G
Front Cardiovasc Med. 2022; 9:836451.
PMID: 35498033
PMC: 9039357.
DOI: 10.3389/fcvm.2022.836451.
Evaluating the adverse outcome of subtypes of heart failure with preserved ejection fraction defined by machine learning: A systematic review focused on defining high risk phenogroups.
Rabkin S
EXCLI J. 2022; 21:487-518.
PMID: 35391918
PMC: 8983850.
DOI: 10.17179/excli2021-4572.
Physical Inactivity Is Associated With Post-discharge Mortality and Re-hospitalization Risk Among Swedish Heart Failure Patients-The HARVEST-Malmö Study.
Zaghi A, Holm H, Korduner J, Dieden A, Molvin J, Bachus E
Front Cardiovasc Med. 2022; 9:843029.
PMID: 35265689
PMC: 8899472.
DOI: 10.3389/fcvm.2022.843029.
Sacubitril-Valsartan, Clinical Benefits and Related Mechanisms of Action in Heart Failure With Reduced Ejection Fraction. A Review.
Pascual-Figal D, Bayes-Genis A, Beltran-Troncoso P, Caravaca-Perez P, Conde-Martel A, Crespo-Leiro M
Front Cardiovasc Med. 2021; 8:754499.
PMID: 34859070
PMC: 8631913.
DOI: 10.3389/fcvm.2021.754499.
Early Measurement of Blood sST2 Is a Good Predictor of Death and Poor Outcomes in Patients Admitted for COVID-19 Infection.
Sanchez-Marteles M, Rubio-Gracia J, Pena-Fresneda N, Garces-Horna V, Gracia-Tello B, Martinez-Lostao L
J Clin Med. 2021; 10(16).
PMID: 34441830
PMC: 8396994.
DOI: 10.3390/jcm10163534.
Pathophysiology and Therapeutic Approaches to Acute Decompensated Heart Failure.
Njoroge J, Teerlink J
Circ Res. 2021; 128(10):1468-1486.
PMID: 33983837
PMC: 8126502.
DOI: 10.1161/CIRCRESAHA.121.318186.
ST2 Is a Biomarker of Pediatric Pulmonary Arterial Hypertension Severity and Clinical Worsening.
Griffiths M, Yang J, Simpson C, Vaidya D, Nies M, Brandal S
Chest. 2021; 160(1):297-306.
PMID: 33609516
PMC: 8295908.
DOI: 10.1016/j.chest.2021.01.085.
Gender-Related Differences in Heart Failure Biomarkers.
Cediel G, Codina P, Spitaleri G, Domingo M, Santiago-Vacas E, Lupon J
Front Cardiovasc Med. 2021; 7:617705.
PMID: 33469552
PMC: 7813809.
DOI: 10.3389/fcvm.2020.617705.
Soluble ST2 as a Biomarker for Early Complications in Patients with Chronic Thromboembolic Pulmonary Hypertension Treated with Balloon Pulmonary Angioplasty.
Banaszkiewicz M, Pietrasik A, Florczyk M, Kedzierski P, Pilka M, Manczak R
Diagnostics (Basel). 2021; 11(1).
PMID: 33467121
PMC: 7830401.
DOI: 10.3390/diagnostics11010133.
Testosterone, cardiomyopathies, and heart failure: a narrative review.
Diaconu R, Donoiu I, Mirea O, Balseanu T
Asian J Androl. 2021; 23(4):348-356.
PMID: 33433530
PMC: 8269837.
DOI: 10.4103/aja.aja_80_20.
